Completed OBSERVATIONAL NCT00487591

An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia

An Evaluation of Simvastatin 20 mg Plus Omacor 4 g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia

Sponsor: Provident Clinical Research

Conditions Mixed Dyslipidemia

Interventions Omacor (omega-3-acid ethyl esters)plus simvastatin simvastatin plus placebo

Updated 11 times since 2017 Last updated: Apr 28, 2008 Started: Nov 30, 2006 Primary completion: Aug 31, 2007 Completion: Aug 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Mixed Dyslipidemia, this trial is completed. The trial is conducted by Provident Clinical Research and has accumulated 11 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: PHASE4 → None
Aug 2017 — Apr 2018 [monthly]

Completed PHASE4
Feb 2017 — Aug 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Provident Clinical Research
Reliant Pharmaceuticals

Data source: Provident Clinical Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.